Neuroscience
-
A specific cellular stress response involving heat shock proteins has been found to reverse the build-up of the toxic proteins linked to dementia. Future research will now look for a way to therapeutically trigger this mechanism.
-
Researchers have homed in on strains of gut bacteria associated with the severity of a common form of stroke. The findings build on research suggesting future therapies targeting the microbiome could reduce a person’s risk, and aid in recovery.
-
A study has presented the most rigorous investigation to date into the long-term cognitive impacts of severe COVID-19. It found persistent cognitive deficits in hospitalized patients equivalent to declines consistent with 20 years of brain aging.
-
The results of a clinical trial offer promising signs that daily doses of an insulin nasal spray could be used to slow age-related cognitive decline. The trial found the treatment to be effective in elderly subjects with and without type 2 diabetes.
-
A study has found a link between increased generosity in old age and levels of a neurochemical called oxytocin. The research found older people with high levels of oxytocin were more likely to donate money to charity and be satisfied with their lives.
-
Compelling research has homed in on a degenerative mechanism that could explain why symptoms such as apathy are the first signs of Alzheimer’s disease. It is possible disrupting this process could slow the progression of Alzheimer’s-related dementia.
-
A new article has proposed a novel hypothesis for the cause of Alzheimer’s, arguing the disease is caused by a damaged blood-brain barrier allowing fatty molecules to invade the brain and trigger a cascade of events resulting in cognitive decline.
-
Hundreds of scientists around the globe have shared data to create the world's first brain growth chart. The project incorporated MRI scans from subjects of all ages to offer a unique portrait of how our brains change over the course of a lifetime.
-
Researchers have reported successful preclinical tests for a nasal spray developed to prevent degeneration associated with Alzheimer’s disease. The treatment was effective at reversing the signs of Alzheimer’s in mice, with human tests two years away.
-
A study has identified 75 genomic regions associated with Alzheimer’s disease. The findings add to a growing hypothesis immune dysfunction drives the disease and also raise the possibility of developing a predictive Alzheimer’s genetic risk test
-
Researchers have uncovered how a certain enzyme triggers the breakdown of nerve fibers in neurodegenerative diseases – and how to potentially switch it off. The find could lead to a new class of drugs that slows the progression of these disorders.
-
BIG's new neuroscience center in Denmark will bring together psychiatry and neuroscience research under one roof. The building's light-filled interior will feature a clever layout that it likens to the folds of the cerebral cortex.
Load More